Published in
Elsevier, The Lancet Oncology, 1(24), p. 64-76, 2023
DOI: 10.1016/s1470-2045(22)00693-3
Links
Tools
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
Journal article published in 2023 by
Roberto Mina 
,
Pellegrino Musto ,
Delia Rota-Scalabrini ,
Laura Paris ,
Barbara Gamberi ,
Angelo Palmas ,
Sara Aquino ,
Paolo de Fabritiis ,
Nicola Giuliani ,
Luca De Rosa ,
Alessandro Gozzetti ,
Claudia Cellini ,
Luca Bertamini ,
Andrea Capra ,
Daniela Oddolo
and other authors.
,
Pellegrino Musto ,
Delia Rota-Scalabrini ,
Laura Paris ,
Barbara Gamberi ,
Angelo Palmas ,
Sara Aquino ,
Paolo de Fabritiis ,
Nicola Giuliani ,
Luca De Rosa ,
Alessandro Gozzetti ,
Claudia Cellini ,
Luca Bertamini ,
Andrea Capra ,
Daniela Oddolo
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 